Market Movers: Declines on October 8, 2026
Font: Financial Modeling Prep • Oct 08, 2026
- AngioDynamics (NASDAQ: ANGO), Apimeds Pharmaceuticals US (AMEX: APUS), and Arqit Quantum (NASDAQ: ARQQ) posted steep declines.
- Leveraged ETFs CRWG and IRE also dropped 15.5%, reflecting the volatility of daily-reset leveraged products.
- Available information does not clearly identify confirmed catalysts for most of the losses.
On October 8, 2026, several stocks and leveraged ETFs recorded sharp declines. AngioDynamics (NASDAQ: ANGO)fell 20.9% to $11.23, despite reporting fiscal Q1 revenue of about $80.9 million and a smaller-than-expected adjusted loss of $0.04 per share.
Apimeds Pharmaceuticals US (AMEX: APUS) dropped 21.8% to $5.51. MindWave Innovations announced a 12-month agreement to build and operate FlashChain, but the available information does not connect the update to Apimeds’ decline.
Arqit Quantum (NASDAQ: ARQQ) lost 18.3% after projecting preliminary second-half fiscal 2026 revenue of $355,000 to $380,000. Leveraged ETFs CRWG and IRE each declined 15.5%, highlighting the risk of products that seek twice the daily move of their underlying stocks.
Market Overview
|
OFAL
OFA Group
|
$0.55
33.59%
|
|
ZBAO
Zhibao Technology Inc. Class A Ordinary Shares
|
$0.06
-2.05%
|
|
T
AT&T Inc.
|
$22.18
-9.81%
|
|
WFF
WF Holding Limited
|
$12.29
499.51%
|
|
OLB
The OLB Group, Inc.
|
$0.50
-9.84%
|
|
FRGT
Freight Technologies, Inc.
|
$0.29
14.55%
|
|
SXTC
China SXT Pharmaceuticals, Inc.
|
$0.15
-56.71%
|
|
VZ
Verizon Communications Inc.
|
$41.65
-8.75%
|
|
SPCX
Space Exploration Technologies Corp.
|
$162.57
1.25%
|
|
SDST
Stardust Power Inc.
|
$0.06
-9.59%
|
